BioNexus Gene Lab Corp. (BGLC) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioNexus Gene Lab Corp.

    NASDAQ: BGLC · Real-Time Price · USD
    5.32
    -0.04 (-0.75%)
    At close: Oct 03, 2025, 3:59 PM
    5.29
    -0.56%
    Pre-market: Oct 06, 2025, 05:22 AM EDT

    BioNexus Gene Lab Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.12 -3.47 -461.48 485.43
    PEG Ratio
    		 0.08 -0.01 3.14 -8.28
    PS Ratio
    		 0.52 0.93 15.03 27.30
    PB Ratio
    		 0.60 0.95 24.65 50.81
    P/FCF Ratio
    		 -2.03 -4.63 330.09 60.82K
    P/OCF Ratio
    		 -2.23 -5.01 297.69 39.83K
    OCF/S Ratio
    		 -0.23 -0.19 0.05 0.00
    Debt / Equity Ratio
    		 0.03 0.01 0.01 0.01
    Quick Ratio
    		 3.10 4.24 2.52 2.42
    Current Ratio
    		 3.81 4.93 3.00 3.07
    Asset Turnover
    		 0.91 0.86 1.25 1.40
    Interest Coverage
    		 -74.42 -186.2 -23.33 81.39
    Return on Equity
    		 -0.19 -0.27 -0.05 0.10
    Return on Assets
    		 -0.15 -0.23 -0.04 0.08
    Return on Invested Capital
    		 -0.18 -0.27 -0.05 0.10
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.14 0.14 0.12 0.16
    Net Profit Margin
    		 -0.17 -0.27 -0.03 0.06
    Pretax Profit Margin
    		 -0.17 -0.27 -0.03 0.08
    Operating Profit Margin
    		 -0.17 -0.27 -0.03 0.08
    FCF Margin
    		 -0.26 -0.2 0.05 n/a
    EBITDA Margin
    		 -0.15 -0.25 -0.02 0.09

    Add to Watchlist